Pharmafile Logo

Behaviour change – is there something missing?

Successful and impactful behaviour change requires commitment and time

- PMLiVE

Meg Morgan, Strategic Solutions Director

There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example. So why is it that some of us ignore the evidence and risk our health? What does it really take to change our thinking, the way we make decisions and how we behave?

While we may think that complex interventions are needed to successfully change behaviours, recent concepts such as Nudge Theory are suggesting otherwise. Nudges are particular types of interventions, the results of which can provide direct insight into a person’s behaviour. For example, providing prescription drugs in different colours to encourage adherence, or painting piano keys on stairs to encourage use instead of the escalator, are immediate impact interventions which have been shown to have a great effect. The impact of nudges can help shape future interventional strategies and therefore can work as part of longer-lasting and larger initiatives.

This is not to suggest that nudges are all it takes to effect a change in behaviour in every case. Bold programmes and interventions that focus on individual needs are shown to have a massive effect too. In 2012 Public Health England launched Stoptober, a national smoking cessation campaign that resulted in a ~50% increase in quitting during October compared with other months in the same year. This showed that designing a campaign with clear behavioural targets and fundamental psychological theory can result in impressive outcomes in an area of health that is notoriously difficult to influence.

So, if we understand our audience better and as a result are able to create highly effective change programmes, have we cracked the code? Probably not.

Trust is another key ingredient. Successful and impactful behaviour change takes understanding, the building of real trust and, because of that, it requires commitment and time. For the pharmaceutical industry this is where our real challenge lies.  Building trust across all operations from research and development, to patient advocacy, to corporate communications means a commitment over time.  The pharmaceutical industry has all the tools and a great opportunity to address this. It already invests hugely in long-term development programmes to understand drug efficacy and safety; the step required to take the same long-term view on implementing behaviour change programmes is not so big. If behavioural aspects are investigated early in the drug life cycle and implemented across all operations and, it will be a real win-win for all involved.

Contact Bedrock Health to talk about the missing link in your behaviour change communication programme.

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Thinking creatively about patient involvement in publications

Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

The value medical communications bring to phase 2/3 of drug development

Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond...

Bedrock expands growing strategy and scientific teams

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Bedrock Healthcare Communications appoints Louise Adamson as Head of Scientific Services

Louise Adamson joins Bedrock as Head of Scientific Services to drive scientific and strategic excellence and grow and develop the scientific team.

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

The award recognises outstanding achievement in flexing thinking and processes to ensure success.